{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:07:24Z","timestamp":1772114844521,"version":"3.50.1"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Additional biomarkers are needed to guide initiation of treatment for Mycobacterium avium pulmonary disease (Mav-PD). Time to positive sputum culture detection (TTP) may offer potential prognostic and monitoring value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To determine whether TTP is associated with infection severity and early treatment response in Mav-PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We undertook a retrospective cohort study of patients with two or more sputum cultures positive for M. avium, an \u201cindex\u201d sputum M. avium isolate during 2015\u20132019, a computed tomographic scan within 6 months, and no treatment for at least 6 months before index sputum. TTP was estimated from the date of laboratory receipt of the specimen to the date of culture positivity confirmation. TTP was tested for association with markers of infection severity (Mav-PD, bronchiectasis, cavitary disease, treatment initiation by 3 and 6 months, and acid fast bacilli [AFB] smear) and treatment response using Mann-Whitney U, Spearman\u2019s correlation coefficient, and Wilcoxon signed-rank tests. We explored a threshold TTP that could identify significant M. avium disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 125 patients with mean (standard deviation) age 68.5 (12.5) years and 65% fulfilled disease criteria. Median TTP was 12 (interquartile range 10\u201315; range 6\u201344) days. TTP and AFB smear grade were negatively correlated (\u03c1 \u22120.58; P\u2009&amp;lt;\u20090.001). TTP was associated with nontuberculous mycobacteria (NTM) disease (P\u2009=\u20090.03), AFB smear positivity (P\u2009&amp;lt;\u20090.001), and treatment initiation by 3 (P\u2009=\u20090.01) and 6 (P\u2009=\u20090.03) months. A threshold TTP of 10 days or less was associated with Mav-PD (80.6% vs. 58.4%; \u00f0 [95% confidence interval (CI)] 22.1% [5.6\u201338.6%]; P\u2009=\u20090.02), AFB smear positivity (83.3% vs. 20.2%, \u00f0 [95% CI] 63.1% [48.3\u201377.9%]; P\u2009&amp;lt;\u20090.001), treatment by 3 (38.9% vs. 13.5%; \u00f0 [95% CI] 25.4% [8.0\u201342.8%]; P\u2009=\u20090.003) and 6 (47.2% vs. 19.1%; \u00f0 [95% CI] 28.1% [9.9\u201346.4%]; P\u2009=\u20090.003) months. After 3 and 6 months of treatment, the median (interquartile range) change in TTP was 8 (1 undefined; P\u2009&amp;lt;\u20090.001) and 7 (0 undefined; P\u2009=\u20090.001) days, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TTP is associated with bacterial burden and infection severity and increases in response to treatment. A threshold of 10 days or less may be useful in predicting significant Mav-PD. As a readily available biomarker, further exploration of TTP is imperative.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.202107-765oc","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T15:39:41Z","timestamp":1638373181000},"page":"925-932","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":12,"title":["Time to Positive Culture Detection Predicts\n                    <i>Mycobacterium avium<\/i>\n                    Pulmonary Disease Severity and Treatment Initiation"],"prefix":"10.1093","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9608-2589","authenticated-orcid":false,"given":"Brett D.","family":"Edwards","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah K.","family":"Brode","sequence":"additional","affiliation":[{"name":"Division of Respirology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Division of Respirology, Department of Medicine, University Health Network, Toronto, Ontario, Canada; and"},{"name":"Department of Respiratory Medicine, West Park Healthcare Centre, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahtab","family":"Mehrabi","sequence":"additional","affiliation":[{"name":"Division of Respirology, Department of Medicine, University Health Network, Toronto, Ontario, Canada; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore K.","family":"Marras","sequence":"additional","affiliation":[{"name":"Division of Respirology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Division of Respirology, Department of Medicine, University Health Network, Toronto, Ontario, Canada; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"2026012203323977300_bib1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciaa241","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"71","author":"Daley","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2026012203323977300_bib2","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1164\/rccm.201111-2016OC","article-title":"Prevalence of nontuberculous mycobacteria lung disease in U.S. Medicare beneficiaries","volume":"185","author":"Adjemian","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203323977300_bib3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/1471-2334-13-231","article-title":"Burden and trends of hospitalisations associated with pulmonary non-tuberculous mycobacterial infections in Germany, 2005-2011","volume":"13","author":"Ringshausen","year":"2013","journal-title":"BMC Infect Dis"},{"key":"2026012203323977300_bib4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3109\/00365548.2012.681695","article-title":"Changing epidemiology of nontuberculous mycobacterial lung disease in South Korea","volume":"44","author":"Lee","year":"2012","journal-title":"Scand J Infect Dis"},{"key":"2026012203323977300_bib5","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.3201\/eid1911.130737","article-title":"Pulmonary nontuberculous mycobacterial disease, Ontario, Canada, 1998-2010","volume":"19","author":"Marras","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"2026012203323977300_bib6","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/thx.2006.070797","article-title":"Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997 2003","volume":"62","author":"Marras","year":"2007","journal-title":"Thorax"},{"key":"2026012203323977300_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0033-1333567","article-title":"Update on the epidemiology of pulmonary nontuberculous mycobacterial infections","volume":"34","author":"Kendall","year":"2013","journal-title":"Semin Respir Crit Care Med"},{"key":"2026012203323977300_bib8","first-page":"1086","article-title":"The incidence of pulmonary non-tuberculous mycobacteria in British Columbia, Canada","volume":"13","author":"Hern\u00e1ndez-Gardu\u00f1o","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026012203323977300_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.bjid.2020.04.012","article-title":"Nontuberculous mycobacterial infection in a tertiary care center in Mexico, 2001-2017","volume":"24","author":"Lopez-Luis","year":"2020","journal-title":"Braz J Infect Dis"},{"key":"2026012203323977300_bib10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203323977300_bib11","author":"CLSI","year":"2008"},{"key":"2026012203323977300_bib12","article-title":"Mycobacterium growth indicator tube time-to-positivity can serve as an early biomarker of treatment response in Mycobacterium avium complex pulmonary disease","author":"Danho","year":"2021","journal-title":"Chest"},{"key":"2026012203323977300_bib13","doi-asserted-by":"crossref","first-page":"1800170","DOI":"10.1183\/13993003.00170-2018","article-title":"Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement","volume":"51","author":"van Ingen","year":"2018","journal-title":"Eur Respir J"},{"key":"2026012203323977300_bib14","first-page":"792","article-title":"Time to detection of Mycobacterium tuberculosis in BACTEC systems as a viable alternative to colony counting","volume":"12","author":"Pheiffer","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026012203323977300_bib15","doi-asserted-by":"crossref","first-page":"e106075","DOI":"10.1371\/journal.pone.0106075","article-title":"Time to culture positivity and sputum smear microscopy during tuberculosis therapy","volume":"9","author":"Olaru","year":"2014","journal-title":"PLoS One"},{"key":"2026012203323977300_bib16","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1469-0691.2011.03626.x","article-title":"Time to liquid culture positivity can substitute for colony counting on agar plates in early bactericidal activity studies of antituberculosis agents","volume":"18","author":"Diacon","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2026012203323977300_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.tube.2013.12.002","article-title":"Time to positivity in liquid culture predicts colony forming unit counts of Mycobacterium tuberculosis in sputum specimens","volume":"94","author":"Diacon","year":"2014","journal-title":"Tuberculosis (Edinb)"},{"key":"2026012203323977300_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tube.2011.01.004","article-title":"Time to detection of Mycobacterium tuberculosis as an alternative to quantitative cultures","volume":"91","author":"Bark","year":"2011","journal-title":"Tuberculosis (Edinb)"},{"key":"2026012203323977300_bib19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1378\/chest.113.2.379","article-title":"Time to detection of Mycobacterium tuberculosis in sputum culture correlates with outcome in patients receiving treatment for pulmonary tuberculosis","volume":"113","author":"Epstein","year":"1998","journal-title":"Chest"},{"key":"2026012203323977300_bib20","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1128\/JCM.01225-12","article-title":"Probability of negative mycobacterium tuberculosis complex cultures based on time to detection of positive cultures: a multicenter evaluation of commercial-broth-based culture systems","volume":"50","author":"Tyrrell","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2026012203323977300_bib21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.diagmicrobio.2008.11.008","article-title":"Differences in time to detection and recovery of Mycobacterium spp. between the MGIT 960 and the BacT\/ALERT MB automated culture systems","volume":"63","author":"Parrish","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2026012203323977300_bib22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.diagmicrobio.2012.09.019","article-title":"Differentiating rapid- and slow-growing mycobacteria by difference in time to growth detection in liquid media","volume":"75","author":"Kim","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2026012203323977300_bib23","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1128\/JCM.36.4.1046-1049.1998","article-title":"Sensitivity of fluorochrome microscopy for detection of Mycobacterium tuberculosis versus nontuberculous mycobacteria","volume":"36","author":"Wright","year":"1998","journal-title":"J Clin Microbiol"},{"key":"2026012203323977300_bib24","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1164\/ajrccm.149.5.8173775","article-title":"Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease","volume":"149","author":"Wallace","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203323977300_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1086\/515597","article-title":"Initial (6-month) results of three-times-weekly azithromycin in treatment regimens for Mycobacterium avium complex lung disease in human immunodeficiency virus-negative patients","volume":"178","author":"Griffith","year":"1998","journal-title":"J Infect Dis"},{"key":"2026012203323977300_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.00011-18","article-title":"Amikacin inhalation as salvage therapy for refractory nontuberculous mycobacterial lung disease","volume":"62","author":"Jhun","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2026012203323977300_bib27","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1164\/rccm.201503-0444OC","article-title":"Semiquantitative culture analysis during therapy for Mycobacterium avium complex lung disease","volume":"192","author":"Griffith","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203323977300_bib28","first-page":"288","article-title":"Typical mycobacteria: their classification","volume":"91","author":"Runyon","year":"1965","journal-title":"Am Rev Respir Dis"},{"key":"2026012203323977300_bib29","doi-asserted-by":"crossref","first-page":"1600537","DOI":"10.1183\/13993003.00537-2016","article-title":"Natural history of Mycobacterium avium complex lung disease in untreated patients with stable course","volume":"49","author":"Hwang","year":"2017","journal-title":"Eur Respir J"},{"key":"2026012203323977300_bib30","doi-asserted-by":"crossref","first-page":"559","DOI":"10.5578\/mb.70088","article-title":"Evaluation of Mycobacterium tuberculosis culture and drug susceptibility test results and the distribution of nontuberculosis mycobacteria from the clinical specimens [in Turkish]","volume":"54","author":"\u00d6zen","year":"2020","journal-title":"Mikrobiyol Bul"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/19\/6\/925\/66331434\/annalsats_19_6_925.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/19\/6\/925\/66331434\/annalsats_19_6_925.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:35:35Z","timestamp":1769070935000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/19\/6\/925\/8418902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6,1]]},"published-print":{"date-parts":[[2022,6,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202107-765oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,6]]},"published":{"date-parts":[[2022,6,1]]},"assertion":[{"value":"2021-07-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}